Jean-Luc Dompé will be out for HSV for the time being. As a replacement, an actor who played hardly any role in the last ...

In his absence, winter signing Alexander Røssing-Lelesiit got a chance on the left wing. The 18-year-old once again showed ...

MILAN--(BUSINESS WIRE)--Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately ...

Dompé is a privately owned biopharmaceutical company with 130 years of history and expertise in life sciences. Headquartered in Milan, the company also has operations in Boston, San Francisco ...

Dompé, a leading biopharmaceutical company with operations in Italy and the US, appointed Shannon K. Sullivan as Chief Commercial Officer (CCO).

MILAN, Nov. 26, 2020 /PRNewswire/ -- Dompé farmaceutici Spa and FarmaMondo entered into an exclusive Managed Access Program distribution agreement appointing the FarmaMondo Group as the exclusive ...

MILAN, June 13, 2022 /PRNewswire/ -- Dompé farmaceutici S.p.A ("Dompé") today announced results from its Phase 2 clinical trial demonstrating that, in patients in severe COVID-19 Pneumonia ...

Dompé pha.r.ma s.p.a. and Axxam s.r.l. announced a research collaboration for the discovery and development of novel drugs based on GPCR targets. "The partnership between Dompé pha.r.ma and Axxam ...

In 2012, Dompé acquired Anabasis, an Italian biotech company that develops innovative drugs based on rhNGF (whose discovery earned Professor Rita Levi Montalcini the Nobel Prize for Medicine) for ...

Dompé is a private, rapidly scaling international biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. The R&D department of the company is anchored by ...